Immuron (IMRN) Operating Leases (2019 - 2022)
Immuron (IMRN) posted quarterly Operating Leases of $150263.8 for Q2 2022, up 851.97% year-over-year from $15784.6 in Q2 2021, and up 851.97% quarter-over-quarter from $15784.6 in Q2 2021.
Immuron (IMRN) Operating Leases (2019 - 2022) Analysis & Trends
Immuron's Operating Leases history runs 4 years deep, the most recent figure standing at $150263.8 for Q2 2022.
- In Q2 2022, Operating Leases rose 851.97% year-over-year to $150263.8; the TTM figure through Jun 2022 stood at $150263.8 (up 851.97% YoY), while the FY2022 annual figure was $150263.8, up 851.97% from the prior year.
- Operating Leases for Q2 2022 stood at $150263.8, up from $15784.6 in the prior quarter.
- The five-year high for Operating Leases was $150263.8 in Q2 2022, with the low at $15784.6 in Q2 2021.
- The 4-year median for Operating Leases is $60098.7 (2020), against an average of $71561.5.
- The sharpest annual moves came in 2021 and 2022: Operating Leases plunged 60.59% in 2021, then soared 851.97% in 2022.
- Immuron's Operating Leases stood at $80148.0 in 2019, then tumbled by 50.03% to $40049.5 in 2020, then slumped by 60.59% to $15784.6 in 2021, then jumped by 851.97% to $150263.8 in 2022.
- Business Quant data shows IMRN's Operating Leases at $150263.8 in Q2 2022, $15784.6 in Q2 2021, and $40049.5 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Immuron | 6.81 Mn | 6.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 150,263.78 |
| Jun 30, 2021 | 15,784.59 |
| Jun 30, 2020 | 40,049.48 |
| Dec 31, 2019 | 80,148.00 |